Moderna reported new clinical data on its COVID-19 vaccine
On Sept. 15, 2021, Moderna announced new analysis suggesting that the Moderna COVID-19 vaccine was highly effective against…
On Sept. 15, 2021, Moderna announced new analysis suggesting that the Moderna COVID-19 vaccine was highly effective against…
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
On Sept. 14, 2021, Emergent BioSolutions announced a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentメs…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 9, 2021, Humanigen announced the U.S. FDA had declined its request for emergency use authorization of…
On Sept. 9, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detected…
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 8, 2021, National Resilience and Moderna announced an agreement to manufacture drug substance for the Moderna…
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
On Sept. 8, 2021, National Resilience announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine. Under…
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
On Sept. 6, 2021, Pfizer and BioNTech announced that they had submitted a variation to the European Medicines…
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
On Sept. 3, 2021, the Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
On Sept. 2, 2021, Adamis Pharma announced the initiation of patient dosing in the Phase 2/3 clinical trial…
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
On Sept. 2 , 2021, an Oxford University Study showed that the most recent common ancestor of these…
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
On Sept. 1, 2021, Quidel announced it will make Quidelメs non-prescription QuickVueᆴ At-Home OTC COVID-19 Test available to…
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
On Aug. 31, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 30, 2021, CureVac announced the publication of its pivotal Phase 2b/3 (HERALD study) primary data of…
On Aug. 30, 2021, AXIMᆴ Biotechnologies announced that the Companyメs manufacturing partner Empowered Diagnostics had filed an amended…